Levy, Antonin <br/><br/>
Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  May 2013 
 - 1898-904 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2013.02.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bevacizumab<br/>Carcinoma, Renal Cell--drug therapy<br/>Cardiovascular Diseases--chemically induced<br/>Disease Progression<br/>Drug Administration Schedule<br/>Everolimus<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Indoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Pyrroles--administration & dosage<br/>Sirolimus--administration & dosage<br/>Sorafenib<br/>Sunitinib<br/>Treatment Outcome<br/>Young Adult